PubRank

Vincenzo O Palmieri

Author PubWeight™ 26.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 2010 3.15
2 Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem 2007 1.62
3 Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research. Curr Med Chem 2006 1.60
4 Esomeprazole-induced central fever with severe myalgia. Ann Pharmacother 2005 1.41
5 Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin Biochem 2005 1.03
6 Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can Fam Physician 2007 0.93
7 Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci (Lond) 2006 0.91
8 Current pharmacological treatment of nonalcoholic fatty liver. Curr Med Chem 2006 0.90
9 Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia. Clin Pharmacol Ther 2005 0.89
10 Avoiding drug interactions: here's help. J Fam Pract 2010 0.87
11 Non-alcoholic fatty liver disease in the metabolic syndrome. Curr Pharm Des 2007 0.87
12 Contribution of canalicular glutathione efflux to bile formation. From cholestasis associated alterations to pharmacological intervention to modify bile flow. Curr Drug Targets Immune Endocr Metabol Disord 2005 0.86
13 Tolerability and safety profile of risperidone in a sample of children and adolescents. Int Clin Psychopharmacol 2013 0.84
14 Mutual changes of thioredoxin and nitrosothiols during biliary cirrhosis: results from humans and cholestatic rats. Hepatology 2007 0.84
15 Transverse leukonychia in severe hypocalcemia. Eur J Dermatol 2004 0.83
16 Effect of dietary restriction and N-acetylcysteine supplementation on intestinal mucosa and liver mitochondrial redox status and function in aged rats. Exp Gerontol 2004 0.82
17 Overview on the mechanisms of drug-induced liver cell death. Ann Hepatol 2004 0.80
18 Improving nonalcoholic fatty liver disease management by general practitioners: a critical evaluation and impact of an educational training program. J Gastrointestin Liver Dis 2008 0.79
19 Assessment of ultrasound acoustic artifacts in patients with acute dyspnea: a multicenter study. Acta Radiol 2012 0.79
20 The emerging problem of nonalcoholic steatohepatitis (NASH). Rom J Gastroenterol 2005 0.78
21 Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents. Int Clin Psychopharmacol 2015 0.78
22 Long-term ursodeoxycholate improves circulating redox changes in primary biliary cirrhotic patients. Clin Biochem 2011 0.78
23 Mitochondrial glutathione content determines the rate of liver regeneration after partial hepatectomy in eu- and hypothyroid rats. J Hepatol 2003 0.77
24 Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C. Hepatology 2004 0.77
25 Hepatotoxicity of polyunsaturated fatty acids in alcohol abuser. J Hepatol 2002 0.77
26 Adefovir dipivoxyl for the treatment of delta-related liver cirrhosis. Ann Pharmacother 2006 0.76
27 The "hemolysis model" for the study of cyto-toxicity and cyto-protection by bile salts and phospholipids. Adv Exp Med Biol 2006 0.75